<DOC>
	<DOCNO>NCT02975297</DOCNO>
	<brief_summary>The purpose study identify potential new treatment smoking cessation .</brief_summary>
	<brief_title>Exenatide Once Weekly Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Be Englishspeaking volunteer desire quit smoking willing make quit attempt course study ; Have smoke ≥10 cigarette day least one year provide breath CO ≥10 ppm ; Have negative pregnancy test , female childbearing potential ; Have HbA1C level 5.7 6.4 % BMI great 25 kg/square meter Not currently use therapy glycemic control ( either injectable [ i.e . insulin ] oral agent ) ; Have vital sign follow : resting pulse 50 95 bpm , BP 90150 mmHg systolic 4595 mmHg diastolic ; Have hematology chemistry laboratory test within reference limit ( within 10 % ) , follow exception : pancreatic test ( lipase amylase ) must within normal limit ; Have medical history brief physical examination demonstrate clinically significant contraindication study participation , judgment principal investigator . Meet criterion follow psychiatric and/or substance use disorder assess MINI : item C ( current manic hypomanic episode ) , I ( alcohol abuse Alcohol Addendumpast 3 month ; current alcohol dependence ) , J ( substance abuse Substance Abuse Addendum past 3 month ; current substance dependence ) , K ( current psychotic disorder current mood disorder psychotic feature ) . Individuals meet criterion nonexclusionary psychiatric disorder consider clinically unstable and/or unsuitable participate determine Principal Investigator and/or Study Physician . Individuals rat moderate ( 916 ) high ( 17 great ) suicidality assess Module B MINI . Have personal family history medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 ; Have type 1 diabetes mellitus ; Have severe cardiovascular disease ( history myocardial infarction , lifethreatening arrhythmia , worsen angina pectoris ) ; Have active temporomandibular joint disease ; Have severe gastrointestinal disease ( i.e . severe gastroparesis ) ; Have previous history pancreatitis risk pancreatitis ; Have CrCl &lt; 30 ; Have previous medically adverse reaction study medication , nicotine , menthol ; Be pregnant lactate unwilling provide negative pregnancy test study entry ; Not use reliable form contraception ( e.g. , abstinence , birth control pill , intrauterine device , condom , spermicide ) ; Have illness opinion primary investigator would preclude safe and/or successful completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>smoking</keyword>
	<keyword>pre-diabetes</keyword>
	<keyword>overweight</keyword>
	<keyword>exenatide</keyword>
	<keyword>GLP-1 agonist</keyword>
</DOC>